Not yet recruiting NCT06714162
A Dietary Supplement Examined for Anti-ageing Effects
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Longevity pill.
- Who it may be relevant to
- Registry conditions: Ageing Signs. Basic parameters: 35 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A 12-week Randomized Controlled Clinical Trial Evaluating the Efficacy of a Dietary Supplement in an Adult Population.
Overview
dietary supplement for healthy ageing
Interventions
- Dietary supplement Longevity pill
vitamins and herbs
Primary outcome measures
- Cogntiion [Time frame: 12 weeks]
Eligibility criteria
Inclusion Criteria: Healthy Adults -
Exclusion Criteria: Diseases deemed to be unable to participate in the study
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06714162 · PR20240502